{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:51:06Z","timestamp":1777355466386,"version":"3.51.4"},"publisher-location":"Berlin, Heidelberg","reference-count":43,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642468384","type":"print"},{"value":"9783642468360","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-3-642-46836-0_3","type":"book-chapter","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T04:36:58Z","timestamp":1333082218000},"page":"15-26","source":"Crossref","is-referenced-by-count":5,"title":["Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin\u2019s Lymphoma"],"prefix":"10.1007","author":[{"given":"C.","family":"Gisselbrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.1986.4.2.160","volume":"4","author":"JO Armitage","year":"1986","unstructured":"Armitage JO, Weisenburger DD, Hutchins M et al (1986) Chemotherapy for diffuse large-cell lymphoma \u2014 rapidly responding patients have more durable remission. J Clin Oncol 4:160\u2013164","journal-title":"J Clin Oncol"},{"key":"3_CR2","first-page":"283","volume":"8","author":"J Baro","year":"1991","unstructured":"Baro J, Richard C, Calavia J et al (1991) Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin\u2019s lymphoma patients with poor prognostic features. Bone Marrow Transplant 8:283\u2013289","journal-title":"Bone Marrow Transplant"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.1992.10.10.1615","volume":"10","author":"A Bosly","year":"1992","unstructured":"Bosly A, Coiffier B, Gisselbrecht C et al (1992) Bone marrow transplantation significantly prolongs survival after relapse in aggressive lymphoma patients treated with the LNH 84 regimen. J Clin Oncol 10:1615\u20131623","journal-title":"J Clin Oncol"},{"key":"3_CR4","doi-asserted-by":"crossref","unstructured":"Brice P, Marolleau JP, Pautier P et al (1996) Hematologic recovery and survival of lymphoma patients after autologous stem cell transplantation (ASCT): comparison of bone marrow with peripheral blood progenitor cell (PBSC). Leuk Lymphoma (in press)","DOI":"10.3109\/10428199609054783"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood.V60.3.693.693","volume":"60","author":"F Cabanillas","year":"1982","unstructured":"Cabanillas F, Hagemeister FB, Bodey GP et al (1982) IMVP 16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60:693\u2013697","journal-title":"Blood"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1200\/JCO.1987.5.3.407","volume":"3","author":"F Cabanillas","year":"1987","unstructured":"Cabanillas F, Hagemeister FB, McLaughlin P et al (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 3:407\u2013412","journal-title":"J Clin Oncol"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R et al (1992) Autologous versus allogenic bone marrow transplantation for non-Hodgkin\u2019s lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 10:1690\u20131695","journal-title":"J Clin Oncol"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.1989.7.8.1018","volume":"7","author":"B Coiffier","year":"1989","unstructured":"Coiffier B, Gisselbrecht C, Herbrecht R et al (1989) LNH 84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018\u20131026","journal-title":"J Clin Oncol"},{"key":"3_CR9","first-page":"399","volume":"4","author":"CN Coleman","year":"1986","unstructured":"Coleman CN, Picozzi VJ, Cox RS et al (1986) Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 4:399\u2013404","journal-title":"J Clin Oncol"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor E, Dahlberg S et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regiments for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med 328:1002\u20131006","journal-title":"N Engl J Med"},{"key":"3_CR11","first-page":"373","volume":"13","author":"AM Gianni","year":"1994","unstructured":"Gianni AM (1994) 5-Year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas. Proc Am Soc Clin Oncol 13:373","journal-title":"Proc Am Soc Clin Oncol"},{"key":"3_CR12","first-page":"195","volume-title":"Cancer research workshop, Grenoble","author":"C Gisselbrecht","year":"1984","unstructured":"Gisselbrecht C, Lepage E, Fermand JP et al (1984) Intensive induction treatment in non-Hodgkin lymphomas with various grades of malignancy. In: Sotto, Vroussos, Vincent (eds) Cancer research workshop, Grenoble. Karger, Basel, pp 195\u2013199"},{"key":"3_CR13","first-page":"561","volume":"93","author":"C Gisselbrecht","year":"1996","unstructured":"Gisselbrecht C, Lepage E, Morel P et al (1996) Short and intensified treatment with autologous stem cell transplantation (ASCT) versus ACVB regimen in poor prognosis aggressive lymphoma (Abstr). Br J Haematol 93:561","journal-title":"Br J Haematol"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJM199211053271903","volume":"327","author":"LI Gordon","year":"1992","unstructured":"Gordon LI, Harrington DP, Andersen J et al (1992) Comparison of a second generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin\u2019s lymphoma. N Engl J Med 327:1342\u20131349","journal-title":"N Engl J Med"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1989.7.11.1621","volume":"7","author":"JG Gribben","year":"1989","unstructured":"Gribben JG, Goldstone AH, Linch DC et al (1989) Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin\u2019s lymphoma who are still responsive to conventional-dose therapy. J Clin Oncol 7:1621\u20131629","journal-title":"J Clin Oncol"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","volume":"325","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Neuberg D et al (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525\u20131533","journal-title":"N Engl J Med"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1988.6.8.1303","volume":"6","author":"SC Gulati","year":"1988","unstructured":"Gulati SC, Shank B, Black P et al (1988) Autologous bone marrow transplantation for patients with poor prognosis lymphoma. J Clin Oncol 6:1303\u20131313","journal-title":"J Clin Oncol"},{"key":"3_CR18","first-page":"1816","volume":"86","author":"C Haioun","year":"1995","unstructured":"Haioun C (1995) Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non-Hodgkin\u2019s lymphoma (NHL) in first complete remission (CR): a study of 542 patients (LNH 87-2 protocol) (Abstr). Blood 86:1816","journal-title":"Blood"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.1994.12.12.2543","volume":"12","author":"C Haioun","year":"1994","unstructured":"Haioun C, Lepage E, Gisselbrecht C et al (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high grade non-Hodgkin\u2019s lymphoma in first complete remission. A study of 464 patients. J Clin Oncol 12:2543\u20132551","journal-title":"J Clin Oncol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood.V86.2.833.bloodjournal862833","volume":"86","author":"C Haioun","year":"1995","unstructured":"Haioun C, Lepage E, Gisselbrecht C et al (1995) Autologous transplantation versus conventional salvage therapy in aggressive non-Hodgkin\u2019s lymphoma (NHL) partially responding to first line chemotherapy. Study of 96 patients enrolled in the LNH 87-2 protocol (Abstr). Blood 86:833","journal-title":"Blood"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","volume":"77","author":"RJ Jones","year":"1991","unstructured":"Jones RJ, Ambinder RF, Piantadosi S et al (1991) Evidence of a graft versus lymphoma effect associated with allogenic bone marrow transplantation. Blood 77:649\u2013653","journal-title":"Blood"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1991.9.10.1848","volume":"9","author":"JH Lundberg","year":"1991","unstructured":"Lundberg JH, Hansen RM, Chitambar CR et al (1991) Allogenic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA identical and alternative donors. J Clin Oncol 9:1848\u20131859","journal-title":"J Clin Oncol"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1200\/JCO.1996.14.2.534","volume":"14","author":"M Martelli","year":"1996","unstructured":"Martelli M, Vignetti M, Zinzani PL et al (1996) High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin\u2019s lymphoma with partial response to front-line chemotherapy: a prospective randomized Italian multicenter study. J Clin Oncol 14:534\u2013542","journal-title":"J Clin Oncol"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","volume":"73","author":"N Milpied","year":"1989","unstructured":"Milpied N, Ifrah N, Kuentz M et al (1989) Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 73:82\u201387","journal-title":"Br J Haematol"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","volume":"10","author":"P Morel","year":"1992","unstructured":"Morel P, Lepage E, Brice P et al (1992) Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 10:1078\u20131085","journal-title":"J Clin Oncol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","volume":"7","author":"SB Murphy","year":"1989","unstructured":"Murphy SB, Fairclough DL, Hutchinson RE et al (1989) Non-Hodgkin\u2019s lymphoma of childhood: an analysis of the histology, staging and response to treatment of 338 cases at a single institution. J Clin Oncol 7:186\u2013193","journal-title":"J Clin Oncol"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V80.5.1130.1130","volume":"80","author":"A Nademanee","year":"1992","unstructured":"Nademanee A, Schmidt G, O\u2019Donnell MR et al (1992) High dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood 80:1130\u20131134","journal-title":"Blood"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","volume":"4","author":"C Patte","year":"1986","unstructured":"Patte C, Philip T, Rodary C et al (1986) Improved survival rate in children with stage III and IV B-cell non-Hodgkin\u2019s lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 4:1219\u20131226","journal-title":"J Clin Oncol"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.1996.14.2.586","volume":"14","author":"R Pettengel","year":"1996","unstructured":"Pettengel R, Radford JA, Morgenstern GR et al (1996) Survival benefit from progenitor-cell transplantation in poor-prognosis non-Hodgkin\u2019s lymphoma. J Clin Oncol 14:586\u2013592","journal-title":"J Clin Oncol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G et al (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high grade non-Hodgkin\u2019s lymphoma. N Engl J Med 316:1493\u20131498","journal-title":"N Engl J Med"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1988.6.7.1118","volume":"6","author":"T Philip","year":"1988","unstructured":"Philip T, Hartman O, Biron P et al (1988) High dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin\u2019s lymphoma. J Clin Oncol 6:1118\u20131124","journal-title":"J Clin Oncol"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"I Philip","year":"1995","unstructured":"Philip I, Guglielmi C, Hagenbeek A et al (1995) A prospective randomized study comparing autologous bone marrow transplantation (ABMT) and salvage chemotherapy (DHAP) in sensitive relapse on non-Hodgkin\u2019s lymphoma (NHL): final analysis of the PARMA study. N Engl J Med 333:1540\u20131545","journal-title":"N Engl J Med"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1200\/JCO.1991.9.2.236","volume":"9","author":"LE Robertson","year":"1991","unstructured":"Robertson LE, Redman JR, Bulter JJ et al (1991) Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. J Clin Oncol 9:236\u2013242","journal-title":"J Clin Oncol"},{"key":"3_CR34","first-page":"46","volume":"31","author":"G Salles","year":"1994","unstructured":"Salles G, Shipp MA, Coiffier B (1994) Chemotherapy of non-Hodgkin\u2019s aggressive lymphomas. Semin Hematol 31:46\u201369","journal-title":"Semin Hematol"},{"issue":"1","key":"3_CR35","first-page":"42","volume":"5","author":"G Santini","year":"1991","unstructured":"Santini G, Congui AM, Coser P et al (1991) Autologous bone marrow transplantation for adult advanced stage adult lymphoblastic lymphoma in first CR: a study of the NHLGSG. Leukemia 5 Suppl 1:42\u201345","journal-title":"Leukemia"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.1996.14.1.214","volume":"14","author":"JG Sharp","year":"1996","unstructured":"Sharp JG, Kessinger A, Mann S et al (1996) Outcome of high-dose therapy and autologous transplantation in non-Hodgkin\u2019s lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol 14:214\u2013219","journal-title":"J Clin Oncol"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA, Harrington DP, Anderson JR et al (1993) Development of a predictive model for aggressive lymphoma: the international Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","volume":"12","author":"JW Sweetenham","year":"1994","unstructured":"Sweetenham JW, Liberti G, Pearce R et al (1994) High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. J Clin Oncol 12:1358\u20131365","journal-title":"J Clin Oncol"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/blood.V86.2.832.bloodjournal862832","volume":"86","author":"JW Sweetenham","year":"1995","unstructured":"Sweetenham JW, Pearce R, Taghipour G et al (1995) Adult Burkitt\u2019s and Burkitt-line non-Hodgkin\u2019s lymphoma (NHL) favourable outcome for patients undergoing high dose therapy and autologous stem cell transplantation (ASCT) in first remission or chemosensitive relapse: results from the EBMT (Abstr). Blood 86:832","journal-title":"Blood"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"71","author":"WS Velasquez","year":"1988","unstructured":"Velasquez WS, Cabanillas F, Salvadore P et al (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara C and dexamethasone (DHAP). Blood 71:117","journal-title":"Blood"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, Gijsbert C et al (1992) Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 10:644\u2013646","journal-title":"J Clin Oncol"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM199504203321601","volume":"332","author":"LF Verdonck","year":"1995","unstructured":"Verdonck LF, Van Putten WLJ, Hagenbeek A et al (1995) Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 332:1045\u20131092","journal-title":"N Engl J Med"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.1993.11.10.1846","volume":"11","author":"MJ Vose","year":"1993","unstructured":"Vose MJ, Anderson JR, Kessinger A et al (1993) High dose chemotherapy and autologous hematopoietic stem cell transplantation for aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 11:1846\u20131851","journal-title":"J Clin Oncol"}],"container-title":["Recent Results in Cancer Research","Advances in Hematopoietic Stem Cell Transplantation and Molecular Therapy"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-46836-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T02:18:25Z","timestamp":1593915505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-46836-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9783642468384","9783642468360"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-46836-0_3","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998]]}}}